Buy Osphos 51 Mg/Ml Solution For Injection, 15 Ml Online

With a 15 ml bottle, this injectable solution provides a convenient and effective solution for horses in need. Experience the benefits of Osphos with our worldwide discreet delivery service, ensuring your horses receive the care they deserve.

Key Benefits:

1. Optimal Bone Health Support: Osphos is specially formulated to support and maintain the bone health of horses. Whether your horse is dealing with navicular syndrome or other bone-related conditions, Osphos offers a comprehensive solution to promote healing and alleviate pain.
2. Innovative Mode of Action: Osphos utilizes a unique mode of action by inhibiting bone resorption. By targeting and inhibiting the activity of osteoclasts, Osphos helps to rebalance bone remodeling, leading to improved bone health and reduced lameness in horses.
3. Long-Lasting Effects: With a single dose of Osphos, your horse can experience long-lasting benefits. The effects of Osphos can last for months, providing sustained support and relief, reducing the need for frequent administration.
4. Veterinarian-Recommended: Osphos is trusted and recommended by veterinarians worldwide. Its efficacy and safety have been demonstrated through extensive research and clinical studies, making it a reliable choice for equine bone health management.
5. Discreet Worldwide Delivery: We understand the importance of convenience and privacy when it comes to veterinary care. With our discreet worldwide delivery service, you can have Osphos conveniently delivered to your doorstep, ensuring prompt and hassle-free treatment for your horses.

How to Use Osphos 51 Mg/Ml Solution for Injection:
Using Osphos is a straightforward process. Follow these steps for optimal usage:

1. Veterinary Consultation: Prior to administering Osphos, it is essential to consult with a qualified veterinarian. They will assess your horse’s condition and provide specific dosage and usage instructions based on their needs.
2. Dosage Preparation: Using a sterile syringe, withdraw the recommended dosage of Osphos 51 Mg/Ml Solution for Injection from the bottle. Follow proper handling and storage guidelines to ensure the integrity of the product.
3. Administration: Administer the injectable solution to your horse as directed by the veterinarian. Utilize proper injection techniques and ensure accurate delivery of the solution.
4. Monitoring and Follow-up: Observe your horse’s response to Osphos and report any changes or concerns to your veterinarian. They may recommend additional follow-up treatments or adjustments in dosage based on the horse’s progress and individual needs.

Please note that Osphos 51 Mg/Ml Solution for Injection should only be used under the guidance and supervision of a qualified veterinarian.

Promote Equine Bone Health with Osphos:
Elevate your horse’s bone health with Osphos 51 Mg/Ml Solution for Injection. Order your 15 ml bottle today from EquicurePharm and take advantage of our discreet worldwide delivery service. Provide your horses with the care they deserve and ensure their well-being with Osphos. Trust in the power of veterinary excellence and unlock a healthier future for your beloved equine companions.

Buy Osphos 51 Mg/Ml Solution For Injection, 15 Ml Buy Osphos 51 mg/ml Solution For Injection Online from us at very competitive prices. We are 100% legit and efficient supplier of performance supplements for equine sports. We offer the best market prices and offer a huge discount for bulk buyers. Packaging and shipping are very discreet and bypass all custom or law enforcement. Delivery through regular and express airmail within 2-3 business days from dispatch.

Why Buy Osphos 51 mg/ml For Horses

Indications for use: For the alleviation of clinical forelimb lameness associated with the bone resorptive processes of the distal sesamoid (navicular bone) in adult horses.

Contraindications:  Do not administer intravenously.  Do not administer to horses less than 4 years of age, due to the absence of data regarding use in growing animals.  Do not administer to horses with impaired renal function. Do not use in cases of known hypersensitivity to the active substance or to any of the excipients.

Special precautions for use in animals: Use caution when administering bisphosphonates to horses with conditions affecting mineral or electrolyte homeostasis, e.g. hyperkalaemic periodic paralysis, hypocalcaemia. Special precautions to be taken by the person administering the veterinary medicinal product to animals

Accidental self-injection of this product may increase the risk of obstructed labour in pregnant women and affect fertility in men. Care should be taken when handling the product to avoid self-injection. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Route of administration

OSPHOS is administered at 1.8 mg/kg by intramuscular injection up to a maximum dose of 900 mg per horse (one vial). Divide the total volume evenly into three separate injection sites. Discard unused vial contents. OSPHOS is provided in a single use vial and does not contain a preservative. If there is no response to initial therapy, the horse should be re-evaluated. For horses that initially respond to OSPHOS but do not maintain their clinical improvement for 6 months, OSPHOS may be re-administered at 3 to 6 month intervals based on recurrence of clinical signs. For horses that respond to OSPHOS and maintain clinical improvement for 6 months, OSPHOS should be re-administered after clinical signs recur.

Results In clinical trials, the success rates were 74.7% for horses treated with OSPHOS and 3.3% for horses treated with saline placebo. The difference in success rates is significant (p-value=0.0028). A horse was considered a treatment success if the lameness grade in the primarily affected limb improved by at least 1 AAEP grade and there was no worsening of lameness grade in the other forelimb on Day 56 post-treatment as compared to the pre-treatment assessment. Of the 86 horses treated with OSPHOS, 8 horses had an improvement of 3 lameness grades, 45 horses improved by 2 lameness grades and 16 horses improved by one lameness grade (raw data).

The clinical effectiveness of OSPHOS noted in the field trial was independent of any corrective shoeing or other therapies for navicular syndrome. Clinical improvement is most evident at 2 months post-treatment. Of the horses that responded to treatment with OSPHOS in the field study, 65% maintained their level of improvement through the 6 month evaluation.

Side effects In field studies, the most common side effects reported were signs of discomfort or nervousness, cramping, pawing and/or colic within 2 hours post-treatment (9% of horses treated:  n=10). Eight out of ten of these horses had resolution of their clinical signs with 10 to 15 minutes of hand walking.  In one horse, clinical signs resolved without hand walking. Only one experienced colic requiring treatment. That horse also developed hives and recovered after treatment with flunixin and dexamethasone.